View Older Stories View More Recent Stories
-
NeoChord Announces $25 Million Series D Financing to Accelerate Development of Two Transcatheter Chordal Repair Programs
-
NeoChord Announces $25 Million Series D Financing to Accelerate Development of Two Transcatheter Chordal Repair Programs
-
UNC-Chapel Hill and Deerfield Management announce the creation of Pinnacle Hill to accelerate the discovery of new medicines
-
Deerfield Provides $125 million Debt Financing to Tris Pharma
-
Deerfield and Stan Rowe Create a Next Generation Therapeutic Device Incubator, NXT Biomedical
-
Nuvo Pharmaceuticals™ Announces Signing of Definitive Agreements to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals
-
Aralez Pharmaceuticals Enters Into Definitive "Stalking Horse" Purchase Agreements For Substantially All Assets
-
Ex-Deerfield partners get prison in case over U.S. agency leaks
-
Epic Sciences Announces Completion of $52 Million Series E Financing
-
Allogene Therapeutics Completes a $120 Million Private Financing
-
University of California San Diego and Deerfield Management Create Poseidon Innovation to Advance Disease-Curing Therapeutics
-
Alimera Sciences Announces Exchange of Series B Preferred Stock for Newly Issued Series C Preferred Stock
-
Nuvo Pharmaceuticals™ Announces Extension of Exclusivity Period with Aralez and Deerfield
-
Form 13F-HR DEERFIELD MANAGEMENT For: Jun 30
-
Orchard Therapeutics Announces $150 Million Series C Financing to Advance Gene Therapy Pipeline
-
Nuvo Pharmaceuticals™ Announces Letter of Intent to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals
-
Aralez Pharma (ARLZ) Announces Agreement to Sell Substantially All Assets to Nuvo Pharmaceuticals Inc. for $110M
-
Aralez Pharmaceuticals To Enter Into Purchase Agreements To Sell Substantially All Assets
-
Aerie Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update
-
MedAvail Completes Financing Round, Adds Express Scripts as New Investor
-
Alector Announces $133 Million in Series E Financing to Advance Broad Portfolio of Immuno-Neurology and Immuno-Oncology Programs
-
Form 4 CONSTELLATION PHARMACEUT For: Jul 23 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
Bridge Medicines Enters Agreement with Memorial Sloan Kettering to Develop Kidney-Specific Delivery Platform for the Treatment of Acute Kidney Injury
-
Aerie Pharmaceuticals Announces Deerfield’s Conversion of Convertible Notes into Aerie Common Stock and Establishment of an Undrawn $100M Credit Facility with Deerfield
-
Form 3 CONSTELLATION PHARMACEUT For: Jul 18 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
Appello Completes $10.5 Million Series A Financing Led by Deerfield Management and Mountain Group Partners
-
Ablexis Targets Market Expansion Opportunities for AlivaMab Mouse Following Acquisition by Deerfield Management and the Founding of AlivaMab Discovery Services
-
Metacrine Completes $65 Million Series C Financing
-
Form 4 Kiniksa Pharmaceuticals, For: May 29 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
Northwestern University and Deerfield Management launch Lakeside Discovery to provide tomorrow's solutions in healthcare
-
Strata Oncology Secures $26 Million in Series B Funding, Led by Pfizer and Merck
-
FogPharma Secures $66 Million Series B Financing
-
Gene Therapy Market, 2030
-
Form 13F-HR DEERFIELD MANAGEMENT For: Mar 31
-
Four found guilty in insider trading case linked to U.S. health agency
-
Adeptus Health Appoints Dr. Nirav R. Shah as Advisor in Residence
-
V-Wave Closes $70M Financing to Support Pivotal Study of its Heart Failure Therapy
-
Adeptus Health Appoints LeAnne Zumwalt to its Board of Directors
-
Neurotechnology Innovations Translator (NIT) Announces Funding of up to $50 Million in Portfolio Company, Sollis Therapeutics
-
CORRECTING and REPLACING Neurotechnology Innovations Translator (NIT) Announces Funding of up to $50 Million in Portfolio Company Sollis Therapeutics
-
Deerfield Leads Investment of up to $50 Million in Sollis Therapeutics' Innovative Solution for Sciatica Pain
-
Constellation Pharmaceuticals Announces $100 Million Financing
-
Arvinas Completes $55 Million Series C Financing to Advance Protein Degradation Platform
-
Bridge Medicines Appoints Louis M. Renzetti, Ph.D., As Chief Scientific Officer
-
Washington insider's 'secret sauce' fueled NY hedge fund, U.S. says at trial
-
Deerfield Management and Vanderbilt University announce the launch of Ancora Innovation
-
Dracen Closes Financing to Advance Immunometabolism Pipeline
-
Deerfield Commits $36 Million to Advance Dracen's Novel Immuno-Metabolism Pipeline
-
DBV Technologies (DBVT) Prices 2.784M ADS Offering at $21.26/ADS as Part of Global Offering
-
DBV Technologies Announces Pricing of $150.0 million (€122.5 million) Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares

